FTIR characterization and release of bovine serum albumin from bioactive glasses

J Appl Biomater Funct Mater. 2017 Nov 10;15(4):e347-e355. doi: 10.5301/jabfm.5000374.

Abstract

Background: Bioactive glass has attracted substantial interest in orthopedics, but it has been less explored as a drug carrier. This study investigated the bovine serum albumin (BSA) release from bioactive 13-93B0 and 13-93B3 glasses.

Methods: Glass disks (13-93B0 and 13-93B3; n = 5) were loaded with 4 mg of BSA and coated under different chitosan-coating conditions. The amount of BSA released in phosphate-buffered saline (PBS) was evaluated, and a degradation study was performed to find out the weight loss and pH of PBS. Secondary structures of BSA on 13-93B0 were characterized by Fourier transform infrared (FTIR) spectroscopy.

Results: One hundred percent protein release occurred by 24 hours for all 13-93B3 groups. However, chitosan coating delayed 100% release up to 72 hours in 13-93B0 groups. The 13-93B3 glass showed higher degradation rates than 13-93B0 regardless of chitosan-coating status. Multilayer and sandwich chitosan coatings further delayed BSA release from 13-93B0. FTIR analysis revealed that α-helical structure was the highest among all groups and significantly higher in the 2% sandwich chitosan coating group (32.0% ± 2.1%), compared with uncoated and 4% chitosan groups.

Conclusions: Chitosan coating can delay the burst release of BSA from 13-93B0 glass and be a potential coating on bioactive glass for drug delivery purposes.

MeSH terms

  • Animals
  • Cattle
  • Chitosan / chemistry
  • Drug Carriers* / chemistry
  • Drug Carriers* / pharmacokinetics
  • Drug Delivery Systems*
  • Glass / chemistry*
  • Materials Testing
  • Porosity
  • Serum Albumin, Bovine / chemistry
  • Serum Albumin, Bovine / pharmacokinetics*
  • Spectroscopy, Fourier Transform Infrared

Substances

  • Drug Carriers
  • Serum Albumin, Bovine
  • Chitosan